Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reticulon-4 (RTN4), also known as Nogo, is a multifunctional protein that plays critical roles in both neural development and endoplasmic reticulum (ER) morphology. It inhibits neurite outgrowth and regulates ER structure and calcium homeostasis, making it a therapeutic target for spinal cord injuries, stroke, and cancer.
Antibody-mediated blockade of RTN4 inhibitory domains to promote neural repair and revascularization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reticulon-4 (RTN4).